Sandy Draper – Truist Securities

Truist Securities

A Truist Securities analyst with 7 tracked ratings across 7 distinct tickers has a hold rating on 1 occasion and an 83.3% success rate on the captured sample, focusing solely on one source.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 years ago

2023-11-14 00:00:00+00

Track record

Aggregated

83% success rate

Bullish: 5
Hold: 2
Bearish: 1

Aggregated

Not available

Recent ratings

Ticker	Date	Rating	Price target	Source
EVH	2023-11-14	hold	$34.00	Aggregated
EVHEVOLENT HEALTH INC - ORDINARY SHARES - CLASS A	2023-11-14	hold	$34.00	Aggregated
SYNH	2021-06-02	buy	$104.00	Aggregated
SYNH-	2021-06-02	unknown	$104.00	Aggregated
CRL	2021-05-25	buy	$369.00	Aggregated
CRLCHARLES RIVER LABORATORIES INTERNATIONAL INC.	2021-05-25	unknown	$369.00	Aggregated
NTRA	2021-05-25	buy	$129.00	Aggregated
NTRANATERA INC	2021-05-25	unknown	$129.00	Aggregated
VCYT	2021-05-18	buy	$55.00	Aggregated
VCYTVERACYTE INC	2021-05-18	unknown	$55.00	Aggregated
EXAS	2021-05-12	buy	$168.00	Aggregated
EXASEXACT SCIENCES CORP.	2021-05-12	unknown	$168.00	Aggregated
AGL	2021-05-10	sell	$40.00	Aggregated
AGLAGILON HEALTH INC	2021-05-10	unknown	$40.00	Aggregated

Tickers covered(14)

Ticker	Ratings	Last rating	Sources
EVH	1	2023-11-14	Aggregated
EVHEVOLENT HEALTH INC - ORDINARY SHARES - CLASS A	1	2023-11-14	Aggregated
SYNH	2	2021-06-02	Aggregated
SYNH-	1	2021-06-02	Aggregated
CRL	2	2021-05-25	Aggregated
CRLCHARLES RIVER LABORATORIES INTERNATIONAL INC.	1	2021-05-25	Aggregated
NTRA	2	2021-05-25	Aggregated
NTRANATERA INC	1	2021-05-25	Aggregated
VCYT	2	2021-05-18	Aggregated
VCYTVERACYTE INC	1	2021-05-18	Aggregated
EXAS	2	2021-05-12	Aggregated
EXASEXACT SCIENCES CORP.	1	2021-05-12	Aggregated
AGL	2	2021-05-10	Aggregated
AGLAGILON HEALTH INC	1	2021-05-10	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.